Antifibrotic treatment in progressive non-IPF fibrotic interstitial lung diseases
A. Llanos-González (Santa Cruz de Tenerife, Spain), J. Bordas Martínez (Barcelona, Spain), G. Bermudo Peloche (Barcelona, Spain), G. Suárez-Cuartín (Barcelona, Spain), V. Vicens Zygmunt (Barcelona, Spain), L. Planas-Cerezales (Barcelona, Spain), J. Palma López (Barcelona, Spain), L. Pérez Martín (Santa Cruz de Tenerife, Spain), R. Jodar Masanes (Barcelona, Spain), N. Padulles Zamora (Barcelona, Spain), S. García Gil (Santa Cruz de Tenerife, Spain), J. Dorca Sargatal (Barcelona, Spain), A. Medina Gonzálvez (Santa Cruz de Tenerife, Spain), O. Acosta Fernández (Santa Cruz de Tenerife, Spain), M. Molina Molina (Barcelona, Spain)
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Session: The world of idiopathic pulmonary fibrosis
Session type: Poster Discussion
Number: 1731
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Llanos-González (Santa Cruz de Tenerife, Spain), J. Bordas Martínez (Barcelona, Spain), G. Bermudo Peloche (Barcelona, Spain), G. Suárez-Cuartín (Barcelona, Spain), V. Vicens Zygmunt (Barcelona, Spain), L. Planas-Cerezales (Barcelona, Spain), J. Palma López (Barcelona, Spain), L. Pérez Martín (Santa Cruz de Tenerife, Spain), R. Jodar Masanes (Barcelona, Spain), N. Padulles Zamora (Barcelona, Spain), S. García Gil (Santa Cruz de Tenerife, Spain), J. Dorca Sargatal (Barcelona, Spain), A. Medina Gonzálvez (Santa Cruz de Tenerife, Spain), O. Acosta Fernández (Santa Cruz de Tenerife, Spain), M. Molina Molina (Barcelona, Spain). Antifibrotic treatment in progressive non-IPF fibrotic interstitial lung diseases. 1731
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: